SynAct Pharma AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	98	111	36	28	217	360
Market Cap Growth	55.07%	206.19%	28.73%	-86.97%	-39.77%	234.62%
Enterprise Value	94	104	33	26	212	356
Last Close Price	1.83	2.02	0.76	0.69	6.95	16.75
PB Ratio	6.26	7.08	1.95	1.78	19.10	177.45
P/TBV Ratio	6.26	7.08	1.95	1.78	19.10	177.45
Debt / Equity Ratio	0.01	0.01	0.01	0.00	0.02	0.15
Net Debt / Equity Ratio	-0.31	-0.31	-0.28	-0.35	-0.84	-1.00
Net Debt / EBITDA Ratio	-	-	3.93	0.82	-	-
Quick Ratio	3.10	3.10	2.66	3.00	8.19	2.25
Current Ratio	3.32	3.32	3.30	3.01	9.34	2.27
Return on Equity (ROE)	-57.65%	-57.65%	-42.22%	-142.59%	-134.62%	-377.30%
Return on Assets (ROA)	-29.67%	-29.67%	-22.48%	-50.54%	-72.92%	-159.60%
Return on Capital Employed (ROCE)	-58.60%	-58.60%	-37.00%	-73.80%	-82.70%	-333.20%
Earnings Yield	-10.40%	-9.20%	-19.77%	-68.71%	-4.11%	-1.87%
Buyback Yield / Dilution	-28.94%	-28.94%	-21.81%	-17.90%	-6.72%	-19.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.